Results 131 to 140 of about 49,464 (141)

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

Annals of Oncology, 2013
G M Jeffery, M B Jameson, V J Harvey
exaly  

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer

Annals of Oncology, 2004
S Y Song, J Y Cho, Y S Hong
exaly  

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients

Annals of Oncology, 2011
David Cunningham, Leonard B. Saltz, P Hoff   +2 more
exaly  

Capecitabine

Reactions Weekly, 2016
openaire   +1 more source

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine

Annals of Oncology, 2004
Thomas A Macek, Mark J Ratain, H L Kindler   +2 more
exaly  

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer

Annals of Oncology, 2009
Francesca Valent, Fabio Puglisi, Giuseppe Damante   +2 more
exaly  

Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?

Annals of Oncology, 2006
S Vukelja, D Maraninchi, R Leonard
exaly  

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

Cancer Treatment Reviews, 2013
Dorte L Nielsen, Anne Polk
exaly  

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study

Annals of Oncology, 2004
George P Stathopoulos, K Syrigos, P Papakotoulas   +2 more
exaly  

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Annals of Oncology, 2007
Jean-François Daisne, J-L Canon, S Roels   +2 more
exaly